What is Paclitaxel?

Category: Prescription Drugs

Most popular types: Taxol Abraxane

false

See also: Doxorubicin-cyclophosphamide-paclitaxel (ACT) Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab (AC-TH) Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab-pertuzumab (AC-THP) Paclitaxel-trastuzumab-pertuzumab (THP) Paclitaxel-trastuzumab (TH)

Paclitaxel is an anticancer drug used in the treatment of breast, nonsmall cell lung, and ovarian cancers; and AIDS-related Kaposi's sarcoma. It has also been used for bladder, cervical, small cell lung, and head and neck cancers.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Ovarian cancer 11 5
Breast cancer 8 2
Lung cancer 4 3
Endometrial cancer 3 5
Bone metastases 1 1

Show all 8 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
5
Moderate
5
Mild
6
None
1

Commonly reported side effects and conditions associated with Paclitaxel

Side effect Patients
Hair loss 5
Fatigue 3
Neuropathy 3
Diarrhea 2
Breathing difficulty 1
Chest tightness 1

Show all 22 reported side effects

Dosages

Based on patients currently taking Paclitaxel

Dosage Patients
6 mg weekly 2
1 mg every 3 weeks 1
78 mg weekly 1

Why patients stopped taking Paclitaxel

Multiple reasons could be selected

Reason Patients
Course of treatment ended 14
Doctor's advice 3
Did not seem to work 1
Other 1
Side effects too severe 1
See all 17 patients who've stopped taking Paclitaxel

Duration

Currently taking Paclitaxel

Duration Patients
1 - 6 months 2
6 months - 1 year 1
1 - 2 years 2
2 - 5 years 1

Stopped taking Paclitaxel

Duration Patients
Less than 1 month 2
1 - 6 months 13
6 months - 1 year 1
2 - 5 years 1
Adherence
Adherence Evaluations
Always 12
Usually 3
Sometimes 2
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 3
Somewhat hard to take 4
A little hard to take 6
Not at all hard to take 4
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 1
$50-99 0
$25-49 0
< $25 8
Not specified 7

What people switch to and from

Patients stopped taking Paclitaxel and switched to:

Treatment Patients
Bevacizumab (Avastin) 1
Eribulin (Halaven) 1
Last updated:

1 patient evaluation for Paclitaxel

Jul 14, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 30 mg Weekly
Advice & Tips: Same effect on RA.

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Paclitaxel